However, these results add to the existing literature about outcomes among women with PIK3CA mutations at diagnosis by suggesting that, among women whose cancer metastasizes, the presence of a PIK3CA mutation may be associated with delayed time to metastasis. This evidence concerns the gene PIK3CA and cancer.